Tag: NYSE:GNK

  • Micro-cap most volatile: Equal Energy (NYSE:EQU), Datawatch (NASDAQ:DWCH), Genco Shipping & Trading (NYSE:GNK), Catalyst Pharmaceutical Partners (NASDAQ:CPRX)

    Montclair Energy, LLC (“Montclair”) announced that it has published a detailed proposal to maximize shareholder value at Equal Energy Ltd. (USA) (NYSE:EQU) through a recapitalization of the Company. Copies of the proposal are available on the web site maintained by the U.S. Securities and Exchange Commission (“SEC”) at http://www.sec.gov. Equal Energy Ltd. (USA) (NYSE:EQU) shares after opening at $4.32 moved to $4.80 on last trade day and at the end of the day closed at $4.68. Company price to sales ratio in past twelve months was calculated as 3.08 and price to cash ratio as 9.93. Equal Energy Ltd. (USA) (NYSE:EQU) showed a positive weekly performance of 5.64%.

    Datawatch Corporation (NASDAQ:DWCH) slumped after the company announced preliminary results for its second fiscal quarter ended March 31, 2014. Datawatch Corporation (NASDAQ:DWCH) shares fell -29.16% in last trading session and ended the day on $14.67. Datawatch Corporation (NASDAQ:DWCH) return on equity ratio is recorded as -31.90% and its return on assets is -21.20%. Datawatch Corporation (NASDAQ:DWCH) yearly performance is -48.44%.

    Genco Shipping & Trading Limited (NYSE:GNK) said it must reach a “definitive agreement” to restructure its debt by April 4 to keep new accords with lenders in place.  Genco Shipping & Trading Limited (NYSE:GNK) shares moved down -1.54% in last trading session and was closed at $1.92, while trading in range of $1.74 – $1.96. Genco Shipping & Trading Limited (NYSE:GNK) year to date (YTD) performance is -23.20%.

    Equities researchers at Piper Jaffray assumed coverage on shares of Catalyst Pharmaceutical Partners (NASDAQ:CPRX) in a research report issued on Monday, TheFlyOnTheWall.comreports. The firm set an “overweight” rating and a $4.00 price target on the stock.  Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) weekly performance is -8.85%. On last trading day company shares ended up $2.06. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) distance from 50-day simple moving average (SMA50) is -3.50%. Analysts mean target price for the company is $4.69.